Groundbreaking research has revealed how ascites—the fluid buildup commonly seen in advanced ovarian cancer—disrupts the immune system and weakens the body’s natural defenses against tumors.
About 70% of ovarian cancer cases are diagnosed at an advanced stage, often with significant fluid accumulation in the abdominal cavity. This condition not only promotes the spread of cancer throughout the abdomen but also severely hinders the immune response. Understanding how this happens is key to improving treatment outcomes.
A research team from Trinity College Dublin and University College Dublin zeroed in on two critical immune cells: natural killer (NK) and T cells. These cells are essential in identifying and eliminating cancer. By analyzing ascites samples from ovarian cancer patients, the team discovered that phospholipids—a type of fat molecule present in the fluid—are major players in suppressing immune function.
The study found that these phospholipids disrupt the metabolism of NK cells, effectively shutting down their ability to fight cancer. However, the researchers also uncovered a promising solution: when they used receptor blockers to prevent NK cells from absorbing these lipids, the cells’ cancer-fighting functions were restored.
NK and T cells routinely identify and destroy cancer cells in a healthy immune system. But in ovarian cancer patients, the lipid-rich environment created by ascites makes this natural defense system ineffective. This discovery highlights lipids’ powerful role in immune suppression and tumor progression.
The findings open a new frontier in ovarian cancer research, with the potential to reshape how immunotherapies are developed. By targeting lipid-induced immune dysfunction, scientists hope to boost the body’s ability to fight back, leading to more effective treatments and better patient outcomes.
This research sheds light on a previously underexplored mechanism of immune suppression and points to a tangible strategy for restoring immune activity, offering new hope in the fight against ovarian cancer.
Most Commented